Hundreds of women have filed Paragard IUD lawsuits claiming that they were injured when a design defect in the popular IUD caused it to fracture during removal and leave foreign objects inside their bodies.
The Paragard lawsuits in the federal courts have been consolidated into a new Paragard MDL in the Northern District of Georgia. In this post, we will speculate on how much these Paragard lawsuits might be worth if the litigation is resolved in a global settlement with the manufacturers.
This post speculates about Zantac lawsuit settlement amounts. Yes, it is impossible to know what the average compensation payout might be in the Zantac litigation at this stage.
But projecting settlement amounts is what stock analysts and shareholders for Sanofi-Aventis, Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are already doing and baking those costs into the stock price. Plaintiffs’ Zantac lawyers can do this as well.
So this post will look at how much these Zantac lawsuits might eventually be worth based on comparisons to other mass tort settlements involving cancer.
Tasigna is a relatively new drug developed by Novartis for the treatment of leukemia. Not long after Tasigna was released in the U.S., evidence emerged indicating that Tasigna could cause a dangerous condition called atherosclerosis (narrowing of the blood arteries to the heart).
Plaintiffs’ lawyers claim that Novartis knew or should have known about this dangerous side-effect, but failed to include a warning in the prescribing information.
Users of Tasigna who suffered vascular damage from this undisclosed side-effect may be entitled to compensation for their injuries. Novartis has already been sued in a growing number of Tasigna lawsuits and a new “class-action” MDL has been created for consolidated handling of the Tasigna cases.
Roundup is one of the most popular and widely used weed killers in the world. Roundup was first released in the early 1970s by Monsanto (now owned by pharma giant Bayer) and it eventually came to dominate the weed killer market, both commercial and residential. Roundup was everywhere and there was never any question about whether it was safe.
The end of Roundup’s success story began about 5 years ago when it was discovered that chronic exposure to the active ingredient in Roundup (glyphosate) could cause certain types of cancer. This discovery was followed by an inevitable tidal wave of lawsuits by individuals who were diagnosed with cancers such as non-Hodgkin’s lymphoma after prolonged use of Roundup.
The Roundup lawsuits soon numbered in the thousands and were consolidated into multidistrict litigation (MDL) in the Northern District of California. Monsanto (and its successor Bayer) has repeatedly refused to admit that Roundup is unsafe and aggressively defended its product in the courts. After years of civil discovery and a series of “test trials” that resulted in massive plaintiff verdicts, Bayer finally gave in and announced in 2020 that it was going to pay a staggering $10 billion to settle all of the Roundup lawsuits.
Earlier this week, WJLA News 7, an ABC affiliate station in Los Angeles, released an investigative spotlight story on the hidden problems with a popular birth control device called Paragard IUD. Earlier this year the station reported finding over 3,200 women who had their Paragard IUD fracture during removal, often leaving sharp pieces inside their bodies.
Reporters for the station continued their investigation and uncovered evidence that the manufacturer of Paragard knew about the problems and may not have done enough to inform consumers.
There is now a Paragard class action lawsuit because of the problems women have experienced with Paragard.
The recent Philips CPAP recall lawsuit has gotten lawyers focused on CPAP machines, how they work, and the risks associated with them.
Below are settlement compensation amounts and verdict payouts in CPAP-related lawsuits.
IVC filters have been linked to an increased risk of fracture which can cause serious injury or death. Our law firm is focused on Cordis and Cook IVC filter cases.
The IVC filter lawsuits have been going on for a long time, too long. Our lawyers frequently get calls from people who are frustrated that their lawyer has “done nothing” to advance their case towards settlement. We also get calls from victims who cannot find a lawyer. This page gives you information if you have filed an IVC filter lawsuit or are thinking of filing such a claim.
Note: 2021 Update Below
Last February, just before the coronavirus shutdowns put everything on pause, the Food and Drug Administration (FDA) issued a Drug Safety Communication for the weight-loss drug Belviq. According to the FDA, studies show that Belviq increases the risk of certain types of cancers. In response to the FDA safety announcement for Belviq, Easai Inc. agreed to voluntarily withdraw the drug from the market. It now appears that Belviq is destined to suffer the same disastrous fate as many other prescription weight control drugs.
Belviq is the brand name for Lorcaserin, a new type of hormone appetite suppressant medication developed for the treatment of obesity. It was originally developed by Arena Pharmaceuticals and later manufactured and sold by Japanese-based pharmaceutical company Eisai.
Yesterday, I wrote about the rising Paragard litigation and the possibility of a class-action lawsuit. Today, I’m writing about the history of IUDs for birth control.
The Paragard IUD is the most recent intrauterine contraceptive device to find itself embattled in a wave of product liability lawsuits in the U.S. Like so many of its predecessors in the IUD market, the Paragard turned out to have a hidden defect that caused serious health problems in many users.
The recently discovered issue with the Paragard is that the device frequently breaks apart when doctors attempt to remove it, causing fractured shards of plastic to poke around inside the uterus. This defect has already prompted a wave of Paragard IUD lawsuits around the country.
Recent studies and reports have found an association between Beovu and retinal vasculitis with vision loss. This comes only months after it received FDA approval.
Brolucizumab-dbll, known by the brand name Beovu, is a vascular endothelial growth factor (VEGF) inhibitor. It is intended to treat wet AMD (age-related macular degeneration). Beovu is manufactured by the Swiss pharmaceutical giant Novartis. It is administered via intravitreal injection. Beovu comes in a 6mg single-use vial. The recommended dose is a monthly injection for the first three months. This is followed by an injection every 8-12 weeks. The FDA approved Beovu in October 2019.
Lawsuit Information Center Blog